Anew antimigraine drug – Tropoxin (3-(3,4,5-trimethoxybenzoyloxyimino)-8-methyl-8-azabicyclo[1–3]octane hydrochloride) – was developed and was found to prevent or significantly weaken the constrictor reactions of cerebral arteries evoked by serotonin (5-HT) or the 5-HT2B/2C receptor agonist meta-chlorophenylpiperazine (m-CPP) in intact animals and in animals with ischemic brain damage. Tropoxin showed affinity for5-HT2 receptors in the brain and had antiaggregatory actions. It had no marked neurotropic properties and did not alter blood pressure responses to noradrenaline, acetylcholine, or histamine. Pilot clinical trials of Tropoxin provided evidence that it has high efficacy in the interictal treatment of frequent and severe migraine attacks.
Similar content being viewed by others
References
A. V. Amelin, Yu. D. Ignatov, and A. A. Skoromets, Migraine (Pathogenesis, Clinical Aspects, Treatment), St. Petersburg Medical Press, St. Petersburg (2001).
N. N. Yakhno, and D. R. Shtul’man, Diseases of the Nervous System. Handbook for Doctors [in Russian], Meditsina, Moscow (2003).
M. Schurks, R. Y. Zee, J. E. Buring, and T. Kurth, Cephalalgia, 30(4), 447 – 456 (2010); Doi: 10.1111/j.1468 – 2982.2009.
P. M. Rist, J. E. Buring, C. S. Kase, et al., Circulation, 122(24), 2551 – 2557 (2010).
W. Dent, B. Stelzhammer, M. Meindl, et al., Headache, 51(10), 1483 – 1492 (2011); Doi: 10.1111/j.1526 – 4610.2011.
A. Pezzini, E. Del Zotto, A. Giossi, et al., Stroke Res. Treatment, 9(2010); Doi:10.4061/2011/304921.
D. Hoyer and G. Martin, Neuropharmacology, 36, 419 – 428 (1997).
A. Panconesi and R. Sicuteri, Cephalalgia, 17, 3 – 14 (1997).
P. J. Goadsby, Headache: The Journal of Head and Face Pain, 51(4), 650 – 653 (2011).
V. Granados-Soto, C. F. Arguelles, H. I. Rocha-Gonzalez, et al., Neuroscience, 165, 561 – 568 (2010).
S. J. Tepper, A. M. Rapoport, and F. D. Sheftell, Arch. Neurol., 59, 1084 – 1088 (2002).
T. Muller and L. Lohse, Clin. Neuropharmacol., 34(6), 206 – 209 (2011).
E. J. Mylecharane, J. Misbach, J. W. Duckworth, and J. W. Lance, Eur. J. Pharmacol., 48, 1 – 9 (1978).
K. Schmuck, C. Ullmer, H. O. Kalkman, et al., Eur. J. Neurosci., 8(5), 959 – 967 (1996).
G. Casucci, V. Villani, and F. Frediani, Neurol. Sci., 29, 123 – 126 (2008).
J. A. Charles, Headache: The Journal of Head and Face Pain, 51(10), 1550 – 1551 (2011).
A. Raizada, S. S. Vittala, M. Q. Najib, et al., Eur. J. Echocardiogr., 12(11), 880 (2011).
R. S. Mirzoyan, S. B. Seredenin, T. S. Gan’shina, et al., Éksperim. Klin. Farmakol., 61(2), 28 – 31 (1998).
L. M. Kostochka, T. S. Gan’shina, R. S. Mirzoyan, and S. B. Seredenin, Khim.-Farm. Zh., 44, No. 9, 6 – 9 (2010); Pharm. Chem. J., 44(9), 472 – 475 (2010).
R. S. Mirzoyan, T. S. Gan’shina, D. V. Maslennikov, et al., BioMed. Res. Intern., Vol. 2014 (2014), Article ID 586501; http://dx.doi.org/10.1155/2014/586501.
R. C. Mirzoyan, M. B. Plotnikov, T. S. Gan’shina, et al., Handbook for Conducting Preclinical Studies of Drugs [in Russian], Grif i K, Moscow (2012), Part 1, pp. 480 – 487.
A. V. Topchyan, R. S. Mirzoyan, and M. G. Balasanyan, Éksperim. Klin. Farmakol., 59(5), 62 – 64 (1996).
A. A. Gorbunov, T. S. Gan’shina, and R. S. Mirzoyan, Éksperim. Klin. Farmakol., 73(9), 13 – 16 (2010).
A. Panconesi and R. Sicuteri, Cephalalgia, 17(1), 3 – 14 (1997).
A. Yu. Sokolov, O. A. Lyubashina, and S. S. Panteleev, Neirokhimiya, 2, 104 – 112 (2011).
R. S. Mirzoyan, A. V. Topchyan, T. S. Gan’shina, and L. M. Kostochka, Éksperim. Klin. Farmakol., 63(3), 21 – 23 (2000).
T. S. Gan’shina, Éksperim. Klin. Farmakol., 66(3), 17 – 20 (2003).
M. D. Ferrari, M. Wilkinson, D. Hirt, et al., Pain, 45(3), 283 – 291 (1991).
S. N. Kozhechkin, L. M. Kostochka, S. G Bezhanyan, et al., Éksperim. Klin. Farmakol., 68(4), 3 – 6 (2005).
T. M. Vasil’eva, G. N. Petrukhina, N. T. Miftakhova, et al., Éksperim. Klin. Farmakol., 68(3), 30 – 33 (2005).
A. V. Amelin, V. E. Ivanov, Yu. D. Ignatov, et al., Éksperim. Klin. Farmakol., 62(4), 14 – 17 (1999).
Author information
Authors and Affiliations
Additional information
Translated from Khimiko-Farmatsevticheskii Zhurnal, Vol. 50, No. 1, pp. 19 – 23, January, 2016.
Rights and permissions
About this article
Cite this article
Gan’shina, T.S., Gorbunov, A.A., Gnezdilova, A.V. et al. Tropoxin – Drug for the Treatment of Migraine. Pharm Chem J 50, 19–23 (2016). https://doi.org/10.1007/s11094-016-1391-4
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11094-016-1391-4